Adicet Bio, Inc. (ACET): Free Cash Flow
-$96.98M
Year ended 2025-12-31
-$84.97M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$96.98M | n/m | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | -$93.50M | n/m | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | -$98.18M | n/m | 2025-03-06, From 2023-01-01 |
| 2022-12-31 | -$61.55M | n/m | 2024-03-19, From 2022-01-01 |
| 2021-12-31 | -$64.10M | n/m | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | -$42.54M | n/m | 2022-03-15, From 2020-01-01 |
| 2019-12-31 | -$28.95M | n/m | 2021-03-12, From 2019-01-01 |
| 2018-12-31 | -$19.06M | n/c | 2021-03-12, From 2018-01-01 |
| 2017-12-31 | -$11.03M | n/a | 2020-03-12, From 2017-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| Adicet Bio, Inc. (ACET) | 2025-12-31 | -$96.98M | n/m |
| Trevi Therapeutics, Inc. (TRVI) | 2025-12-31 | -$42.10M | n/m |
| Foghorn Therapeutics Inc. (FHTX) | 2025-12-31 | -$86.15M | n/m |
| Fortress Biotech, Inc. (FBIO) | 2024-12-31 | -$80.19M | n/m |
| Lexicon Pharmaceuticals, Inc. (LXRX) | 2025-12-31 | -$67.85M | n/m |
| Alto Neuroscience, Inc. (ANRO) | 2025-12-31 | -$51.79M | n/m |
| UroGen Pharma Ltd. (URGN) | 2025-12-31 | -$162.73M | n/m |
| Benitec Biopharma Inc. (BNTC) | 2026-06-30 | -$16.62M | n/m |
| COMPASS Pathways plc (CMPS) | 2024-12-31 | -$119.19M | n/m |
Compare ACET, TRVI, FHTX, FBIO side by side · Screen every company in Pharmaceutical Preparations ↗